SCHEMBL2239277

SCHEMBL2239277

O=C(/C=C/c1cccc(O)c1)c1cc(Cl)ccc1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
AR P10275 4/20 0.76
MGAM O43451 1/20 0.70
GAA P10253 1/20 0.70
SI P14410 1/20 0.70
MGAM2 Q2M2H8 1/20 0.70
MAOB P27338 3/20 0.69
MAOA P21397 2/20 0.69
HSP90AA1 P07900 1/20 0.69
GUSB P08236 2/20 0.68
KDM4E B2RXH2 1/20 0.64
ALDH1A1 P00352 1/20 0.64
MAPT P10636 1/20 0.64
PKM P14618 1/20 0.64
KMT2A Q03164 1/20 0.64
TDP1 Q9NUW8 1/20 0.64
NR1H4 Q96RI1 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2239280 1.00 AR (0.76) ARMGAMGAASIMGAM2
SCHEMBL10830021 0.87 AR (1.00) ARMAOBMAOAGUSBKDM4E
SCHEMBL11050763 0.87 AR (1.00) ARMAOBMAOAGUSBKDM4E
SCHEMBL18722931 0.86 MAOB (0.73) ARMAOBMAOAKDM4EALDH1A1
SCHEMBL25219942 0.86 CXCL12 (0.63) ARMGAMGAASIMGAM2
SCHEMBL14692621 0.85 NR1H4 (0.79) ARMAOBMAOAMAPTNR1H4
SCHEMBL14692619 0.85 NR1H4 (0.79) ARMAOBMAOAMAPTNR1H4
SCHEMBL5085100 0.83 AR (0.88) ARMAOBMAOAGUSBKDM4E
SCHEMBL5085108 0.83 AR (0.88) ARMAOBMAOAGUSBKDM4E
SCHEMBL25188844 0.82 MAOB (1.00) GAAMAOBMAOAHSP90AA1GUSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2227253-B1 VACCINE COMPRISING MONOCYTE OR IMMATURE MYELOID CELLS(IMC) WHICH WERE LOADED WITH THE LIGAND OF NATURAL KILLER T CELL AND ANTIGEN CELLID CO LTD (KR) 2017-05-17 EP disclosed
US-9518126-B2 Vaccine comprising monocyte or immature myeloid cells (IMC) which were loaded with the ligand of natural killer T cell and antigen CELLID CO., LTD. (KR) 2016-12-13 US disclosed
EP-2029165-B1 B CELL-BASED VACCINE LOADED WITH THE LIGAND OF NATURAL KILLER T CELL AND ANTIGEN CELLID CO LTD (KR) 2014-12-03 EP disclosed
US-8003093-B2 B cell-based vaccine loaded with the ligand of natural killer T cell and antigen SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) 2011-08-23 US disclosed
US-7999089-B1 RNA aptamers and the uses thereof INDUSTRY-ACADEMIC COOPERATION FOUNDATION, DANKOOK UNIVERSITY (KR) 2011-08-16 US disclosed
EP-2227253-A1 VACCINE COMPRISING MONOCYTE OR IMMATURE MYELOID CELLS(IMC) WHICH WERE LOADED WITH THE LIGAND OF NATURAL KILLER T CELL AND ANTIGEN Seoul National University Industry Foundation (KR) 2010-09-15 EP disclosed
US-20100028380-A1 B CELL-BASED VACCINE LOADED WITH THE LIGAND OF NATURAL KILLER T CELL AND ANTIGEN SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) 2010-02-04 US disclosed
US-20090285851-A1 VACCINE COMPRISING MONOCYTE OR IMMATURE MYELOID CELLS (IMC) WHICH WERE LOADED WITH THE LIGAND OF NATURAL KILLER T CELL AND ANTIGEN SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) 2009-11-19 US disclosed
WO-2009066824-A1 VACCINE COMPRISING MONOCYTE OR IMMATURE MYELOID CELLS(IMC) WHICH WERE LOADED WITH THE LIGAND OF NATURAL KILLER T CELL AND ANTIGEN SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) 2009-05-28 WO disclosed
WO-2007043784-A1 RNA APTAMERS AND THE USES THEREOF INDUSTRY-ACADEMIC COOPERATION FOUNDATION, DANKOOK UNIVERSITY (KR) 2007-04-19 WO disclosed